Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of Mortality in Severe SARS-Cov-2 Infection Caused by the 501Y.V2 Variant and B.1.1.7 Variant

NCT04906850 is registered in ClinicalTrials.gov with Centre Hospitalier Régional Metz-Thionville as lead sponsor.

NCT NCT04906850
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04906850 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of Mortality in Severe SARS-Cov-2 Infection Caused by the 501Y.V2 Variant and B.1.1.7 Variant
Lead sponsor
Centre Hospitalier Régional Metz-Thionville
Phase
Observational
Overall status
Completed
Start date
March 1, 2021
Completion date
May 15, 2021
Enrollment
250 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

covid19